Phase 2 Study to Assess Safety, Tolerability and Efficacy of Once Weekly SC PB1046
in Subjects With Symptomatic PAH
Does the drug PB1046 help patients who have pulmonary arterial hypertension?
Basic Study Information
Purpose:Location: University of Rochester Medical Center
Pulmonary arterial hypertension (PAH) is one form of a broader condition known as
pulmonary hypertension, which means high blood pressure in the lungs.
This is a multi-center, randomized, double-blind, controlled, Phase 2 study to assess
the safety, tolerability, and efficacy of PB1046 in patients with pulmonary arterial
Study Contact InformationStudy Coordinator: Andrew Mintz, RN
Phone: (585) 486-0869
Additional Study Details
Trial Not Found
The study you are looking for is not active at this time.
Return to Search